Skip to main content
FinSpry Logo
FinSpry
JAZZ logo
JAZZ
(NASDAQ)
Jazz Pharmaceuticals plc
$230.25-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Jazz Pharmaceuticals (JAZZ) Stock Price & Financial Analysis

Jazz Pharmaceuticals Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$222.93 - $230.94
52-Week High$243.32
52-Week Low$105.00
Open$225.27
Volume860.93K
Average Volume (3M)932.34K
Market Cap15.22B
Shares Outstanding66.10M
P/E Ratio (TTM)506.33
Price to Sales (P/S)3.36
Price to Book (P/B)3.29
EV/EBITDA34.01
Revenue (TTM)4.44B
Net Income (TTM)29.49M
Free Cash Flow (TTM)1.15B
EPS (TTM)$0.47
Profit Margin0.66%
Operating Margin32.49%
Return on Equity (ROE)0.65%
Debt to Equity1.20
50-Day MA$220.81
200-Day MA$175.52
52-Week Change110.14%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Jazz Pharmaceuticals

What is the current stock price for JAZZ?

As of the latest trading session, JAZZ stock trades at $230.25. The 52-week range is $105.00–$243.32, with a day range of $222.93–$230.94.

What is the P/E ratio for JAZZ?

Jazz Pharmaceuticals's trailing P/E ratio is 506.3, meaning investors pay $506.3 for every $1 of annual earnings. Jazz Pharmaceuticals operates in the Healthcare sector.

Does JAZZ pay dividends?

Jazz Pharmaceuticals does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for JAZZ?

Based on 21 analysts, the consensus for JAZZ is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of JAZZ?

Jazz Pharmaceuticals's market capitalization is $15.22B, classifying it as a large-cap company. Jazz Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.